Market Overview - The personal care products sector increased by 0.79% on November 12, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 9.97, up 12.15% with a trading volume of 328,200 shares and a turnover of 319 million yuan [1] - Reliable Co., Ltd. (301009) closed at 14.82, up 6.39% with a trading volume of 206,500 shares and a turnover of 302 million yuan [1] - Two-sided Needle (600249) closed at 7.00, up 3.09% with a trading volume of 456,100 shares and a turnover of 320 million yuan [1] - Other notable performances include Yiyi Co., Ltd. (001206) up 2.72% and Zhongshun Jiesang (002511) up 0.96% [1] Capital Flow - The personal care products sector saw a net inflow of 115 million yuan from institutional investors, while retail investors experienced a net outflow of 110 million yuan [2] - The sector's main stocks showed varied capital flows, with Reliable Co., Ltd. receiving a net inflow of 50.84 million yuan from institutional investors [3] - Yanjiang Co., Ltd. had a net inflow of 22.24 million yuan, while Yiyi Co., Ltd. saw a net inflow of 17.75 million yuan [3]

Core Insights - Jeya Co., Ltd. experienced a stock decline of 1.45% on November 11, with a trading volume of 34.71 million yuan [1] - The company reported a financing net buy of -1.86 million yuan on the same day, indicating a higher level of financing repayment compared to new purchases [1] - As of November 11, the total financing and securities lending balance for Jeya Co., Ltd. was 40.37 million yuan, representing 1.08% of its market capitalization [1] Financial Performance - For the period from January to September 2025, Jeya Co., Ltd. achieved a revenue of 565 million yuan, reflecting a year-on-year growth of 38.44% [2] - The net profit attributable to shareholders for the same period was 67.90 million yuan, marking a significant increase of 95.78% year-on-year [2] - The company has distributed a total of 150 million yuan in dividends since its A-share listing, with 89.06 million yuan paid out in the last three years [2] Shareholder Information - As of October 31, 2025, the number of shareholders for Jeya Co., Ltd. increased to 8,836, a rise of 16.57% from the previous period [2] - The average number of circulating shares per shareholder decreased by 14.21% to 7,310 shares [2] - Several new institutional investors have entered the top ten circulating shareholders, including multiple funds from Caitong Asset Management [2]

Market Overview - The personal care products sector experienced a decline of 0.31% on November 11, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - Notable gainers in the personal care sector included: - Zhongshun Jiesang (002511) with a closing price of 8.36, up 2.20% [1] - Yiyi Co., Ltd. (001206) at 32.00, up 1.68% [1] - Liangmian Needle (600249) at 6.79, up 1.34% [1] - Conversely, Baiya Co., Ltd. (003006) saw a significant decline of 3.04%, closing at 22.30 [2] - Other notable decliners included: - Yanjing Co., Ltd. (300658) down 2.74% [2] - Jiya Co., Ltd. (301108) down 1.45% [2] Capital Flow Analysis - The personal care products sector saw a net outflow of 39.54 million yuan from institutional investors, while retail investors contributed a net inflow of 94.74 million yuan [2][3] - The detailed capital flow for selected stocks showed: - Yiyi Co., Ltd. had a net inflow of 5.18 million yuan from institutional investors [3] - Zhongshun Jiesang experienced a net outflow of 19.48 million yuan from retail investors [3] - Reliable Co., Ltd. (301009) had a significant net outflow of 9.51 million yuan from institutional investors [3]

Market Overview - The personal care products sector increased by 3.74% on November 10, with Yiyi Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] Stock Performance - Yiyi Co., Ltd. (001206) closed at 31.47, up 10.00% with a trading volume of 100,400 shares and a transaction value of 306 million [1] - Other notable performers include: - Stable Medical (300888) at 43.30, up 5.61% [1] - Dengkang Oral (001328) at 37.90, up 4.04% [1] - Reliable Co., Ltd. (301009) at 13.88, up 3.27% [1] - HaoYue Nursing (6009509) at 33.33, up 2.87% [1] Capital Flow - The personal care products sector saw a net inflow of 113 million from main funds, while retail investors experienced a net outflow of approximately 99.87 million [2][3] - Main fund inflows were led by Yiyi Co., Ltd. with 55.37 million, accounting for 18.09% of the total [3] - Stable Medical had a main fund inflow of 39.87 million, representing 6.43% of the total [3] Individual Stock Capital Flow - Reliable Co., Ltd. had a main fund inflow of 9.37 million, with retail investors showing a net outflow of 2.44 million [3] - Other stocks with significant capital flow include: - Dengkang Oral with a main fund inflow of 1.54 million and a retail outflow of 470,980 [3] - Baiya Co., Ltd. (003006) with a main fund inflow of 6.94 million and a retail outflow of 2.32 million [3]

1. Report Industry Investment Rating - The industry rating is "Bullish" [1] 2. Core Views of the Report - The cosmetics industry continues to show differentiation, with brand demand being weak in the off - season, agents seeking change in difficult situations, and producers seizing supply - chain reconstruction opportunities. The medical aesthetics industry has new entrants with better - than - expected shipments, and new product catalysts are worth attention [3][4] 3. Summaries According to Relevant Catalogs 3.1 Cosmetics: Continued Differentiation 3.1.1 Brand Merchants - In 1 - 3Q25, beauty brand merchants' revenue was 28.4 billion yuan, a year - on - year decrease of 0.6%; personal care brand merchants' revenue was 5.7 billion yuan, a year - on - year increase of 12.4%. In 3Q25, beauty and personal care brand merchants' revenues were 8.05 billion and 1.805 billion yuan, a year - on - year decrease of 1.3% and an increase of 7.6% respectively. Beauty revenue weakened quarter - on - quarter, while personal care remained flat [18] - Beauty: Affected by the earlier Double Eleven promotion, consumer enthusiasm declined in September, and brands reduced live - streaming activities. In terms of single - quarter revenue growth, Shuiyang Co., Ltd. and Shanghai Jahwa increased by over 20%, Marubi Co., Ltd. had double - digit growth, Proya had low - double - digit decline, and Betaine and Freda had high - single - digit decline [18] - Personal care: Runben Co., Ltd.'s Q3 revenue increased by 17% year - on - year, with a slight increase in growth rate quarter - on - quarter. Baiya Co., Ltd.'s 3Q25 revenue improved, and Dengkang Oral Care had steady growth [18] - In 1 - 3Q25, beauty brand merchants' net profit after non - recurring items was 2.33 billion yuan, a year - on - year decrease of 15%; personal care brand merchants' was 604 million yuan, a year - on - year decrease of 3.4%. Some companies showed initial cost - control effects [24] 3.1.2 Agents - Agents are seeking change in difficult situations by exploring three paths: incubating self - owned brands (represented by Ruoyuchen), using AI to reduce costs and increase efficiency (represented by Yiwow), and expanding high - growth categories (such as Qingmu Technology expanding into trendy toy agency operations) [30] - Ruoyuchen's self - owned brands Feicui and Zhanjia continued to gain momentum. In Q3, self - owned brand revenue was 451 million yuan, a year - on - year increase of 344.5%, accounting for 55.1%. Zhanjia's Q3 revenue was 227 million yuan, a year - on - year increase of 119%, and 1 - 3Q revenue was 680 million yuan. Feicui's Q3 revenue was 203 million yuan, a quarter - on - quarter increase of over 98.8%, and 1 - 3Q revenue was 362 million yuan [30] 3.1.3 Producers - Demand continued to recover, and the revenue of the producer sector increased by 9%, 17%, and 30% year - on - year from Q1 to Q3, with the growth rate increasing quarter by quarter [33] - QingSong Co., Ltd. focused on optimizing customers and product structure, and its profit turned positive for four consecutive quarters from 2Q24 to 1Q25. Jieya Co., Ltd. had increasing orders from overseas big customers, and its Q3 performance growth accelerated. Jiaheng Home Co., Ltd. increased revenue but not profit, mainly due to the short - term impact of the Huzhou base's capacity ramp - up [33] 3.2 Medical Aesthetics: New Entrants with Better - than - Expected Shipments 3.2.1 Upstream Consumables - The growth rate of demand expansion slowed down, and supply - side competition intensified. In terms of the cumulative number of Class III medical device approvals, hyaluronic acid > regenerative (Sculptra/Poly - L - Lactic Acid) > botulinum toxin > recombinant collagen. Old products of hyaluronic acid and regenerative types faced growth pressure, and the growth rate of recombinant collagen Class III medical device products slowed down significantly quarter - on - quarter [38] - Hyaluronic acid: Aimeike's revenue growth rate from 24Q1 to 25Q3 was + 28.2%/+2.3%/+1.1%/ - 7%/ - 18%/ - 25%/ - 21% year - on - year, showing a quarterly decline since 24Q2 [38] - Collagen: Jinbo Biotech's revenue growth rate from 24Q1 to 25Q1 was + 76%/+100%/+92%/+73%/+63% year - on - year, and in 2Q25/3Q25, it was + 30%/+13% year - on - year. On October 23, the "Recombinant Type I α1 Subtype Collagen Freeze - Dried Fiber" Class III medical device certificate of Giant Biogene was approved by NMPA [38] - Leapmed Medical's medical aesthetics shipments were better than expected, with Q3 medical service and health management business revenue of 320 million yuan, a year - on - year increase of 28%, and the revenue of Sculptra and Hydrodermabrasion reaching 86.1367 million yuan [36] 3.2.2 Downstream - The new model of Xinoxygen Medical Clinics showed high - growth potential. The Q3 revenue guidance was 150 - 170 million yuan, a year - on - year increase of 231% - 275%, and a quarter - on - quarter increase of 4% - 18%. It plans to implement the "100 - City, 1000 - Store" plan in the long term [40] - Stores are expanding from first - tier cities to new first - tier and second - tier cities. As of November 6, it covered 42 stores in 10 cities. The promotion of self - owned brands was remarkable, and it cooperated with Xihong Miracle Sculptra 3.0, priced at 2999 yuan, which was officially launched on September 25 [43] 3.3 Investment Recommendations - Brands with upward potential and both growth and certainty: Recommend Maogeping (Oriental aesthetics, dual - wheel drive of makeup and skincare, and the second - curve of perfume is worth looking forward to) and Shangmei Co., Ltd. (with one cornerstone brand, five growth brands, and N seed businesses) [8][46] - Companies with new product pipelines and expected performance elasticity: Pay attention to Giant Biogene and Leapmed Medical [8][46] - Companies in strategic adjustment and expected to reach an inflection point: Recommend Shuiyang Co., Ltd. (the effect of high - end transformation is gradually emerging), and pay attention to Shanghai Jahwa, Betaine, and Freda [8][46]

Core Viewpoint - The company, Jieya Co., Ltd., has established a wholly-owned subsidiary, Jieya Investment (Hainan) Co., Ltd., with an investment of 200 million RMB to enhance supply chain security and overall competitiveness [1] Group 1 - The establishment of the subsidiary aims to improve the integration of upstream and downstream resources within the industry [1] - The subsidiary has completed the registration process and obtained a business license from the Hainan Provincial Market Supervision Administration [1] - The investment is part of the company's strategy to enhance its profitability and competitive strength [1]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-083 为进一步保障供应链安全，完善产业链，整合产业链上下游资源，提升铜陵 洁雅生物科技股份有限公司（以下简称"公司"）整体竞争实力和盈利能力，公 司以自有资金 2 亿元人民币设立全资子公司洁雅投资（海南）有限责任公司（以 下简称"海南子公司"）。近日，海南子公司完成了工商注册登记手续并取得了 海南省市场监督管理局核发的营业执照。 根据《深圳证券交易所创业板股票上市规则》《公司章程》等有关规定，本 次设立全资子公司在公司总经理审批权限范围内，无需提交董事会及股东会审 议。 本次投资不构成关联交易，也不构成《上市公司重大资产重组管理办法》规 定的重大资产重组。 二、新设立公司基本情况 名称：洁雅投资（海南）有限责任公司 统一社会信用代码：91460000MAK0PNG98X 铜陵洁雅生物科技股份有限公司 关于投资设立全资子公司并完成工商注册登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 经营范围：一般经营项目：以自有资金从事投资活动；创业投资（限投资未 上市企业）；信息 ...

Market Overview - The personal care products sector increased by 0.76% on November 7, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 9.15, up 2.35% with a trading volume of 122,400 shares and a turnover of 112 million yuan [1] - Beijia Clean (603059) closed at 31.80, up 2.09% with a trading volume of 31,500 shares and a turnover of 99.4 million yuan [1] - Stable Medical (300888) closed at 41.00, up 1.91% with a trading volume of 77,500 shares and a turnover of 318 million yuan [1] - Other notable stocks include Jeya Co., Ltd. (301108) up 0.91% and Baiya Co., Ltd. (003006) up 0.58% [1] Fund Flow Analysis - The personal care products sector experienced a net outflow of 12.73 million yuan from institutional investors, while retail investors saw a net inflow of 5.30 million yuan [2] - The overall fund flow indicates a mixed sentiment, with institutional investors pulling back while retail investors showed interest [2] Individual Stock Fund Flow - Yiyi Co., Ltd. (001206) had a net inflow of 9.33 million yuan from institutional investors but a net outflow of 18.01 million yuan from retail investors [3] - Yanjiang Co., Ltd. (300658) saw a net inflow of 5.49 million yuan from institutional investors but a net outflow of 7.83 million yuan from retail investors [3] - Stable Medical (300888) had a net inflow of 2.14 million yuan from institutional investors and a net outflow of 15.55 million yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a decline of 0.3% on November 6, with Runben Co., Ltd. leading the drop. Meanwhile, the Shanghai Composite Index rose by 0.97% to close at 4007.76, and the Shenzhen Component Index increased by 1.73% to 13452.42 [1]. Group 1: Market Performance - The personal care products sector saw a mixed performance among individual stocks, with notable gainers including Beijiajie (+1.53%) and Liangmianjin (+1.08%), while Runben Co., Ltd. led the decline at -1.86% [1][2]. - The trading volume for Beijiajie was 21,300 hands, with a transaction value of approximately 65.74 million yuan, while Runben Co., Ltd. had a trading volume of 41,700 hands and a transaction value of about 108 million yuan [1][2]. Group 2: Capital Flow - The personal care products sector experienced a net outflow of 23.85 million yuan from institutional investors, while retail investors saw a net inflow of 15.48 million yuan [2]. - Among individual stocks, Liangmianjin attracted a net inflow of 11.18 million yuan from institutional investors, while Runben Co., Ltd. faced a net outflow of 1.36 million yuan [3].

Group 1 - The company, Jieya Co., stated that as of October 31, 2025, the total number of shareholders is 8,836 [2]